526853 Stock Overview
Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Bilcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹61.33 |
| 52 Week High | ₹95.40 |
| 52 Week Low | ₹42.47 |
| Beta | 1.15 |
| 1 Month Change | 4.95% |
| 3 Month Change | -26.37% |
| 1 Year Change | 33.21% |
| 3 Year Change | 10.11% |
| 5 Year Change | 147.80% |
| Change since IPO | -45.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| 526853 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | 0.03% | -3.3% | -1.6% |
| 1Y | 33.2% | 15.6% | 45.0% |
Return vs Industry: 526853 exceeded the Indian Life Sciences industry which returned 15.6% over the past year.
Return vs Market: 526853 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| 526853 volatility | |
|---|---|
| 526853 Average Weekly Movement | 7.7% |
| Life Sciences Industry Average Movement | 6.2% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 526853's share price has been volatile over the past 3 months.
Volatility Over Time: 526853's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 70 | Mohan Bhandari | www.bilcare.com |
Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally. The company offers various specialty polymer films and aluminum foils primarily used for packaging of solid dosage pharmaceutical products. It also engages in the provision of the clinical supplies, and research and development services.
Bilcare Limited Fundamentals Summary
| 526853 fundamental statistics | |
|---|---|
| Market cap | ₹1.46b |
| Earnings (TTM) | ₹238.66m |
| Revenue (TTM) | ₹7.81b |
6.1x
P/E Ratio0.2x
P/S RatioIs 526853 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 526853 income statement (TTM) | |
|---|---|
| Revenue | ₹7.81b |
| Cost of Revenue | ₹5.33b |
| Gross Profit | ₹2.48b |
| Other Expenses | ₹2.24b |
| Earnings | ₹238.66m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | 10.14 |
| Gross Margin | 31.78% |
| Net Profit Margin | 3.06% |
| Debt/Equity Ratio | 108.2% |
How did 526853 perform over the long term?
See historical performance and comparison